COVID-19患者-话题@MedSci

#COVID-19患者#

185篇内容 | 4020人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1297498, encodeId=5dc8129e4984e, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Crit Care：COVID-19患者使用皮质类固醇治疗的疗效, objectType=article, longId=204578, objectId=38e62045e8d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38e62045e8d7, replyNumber=0, likeNumber=54, createdTime=2020-12-17, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38e62045e8d7, moduleTitle=Crit Care：COVID-19患者使用皮质类固醇治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38e62045e8d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297497, encodeId=6e81129e497f9, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Ann Neurol：Covid-19患者Guillain-Barré综合征的发病率、临床特征、危险因素和结局, objectType=article, longId=204447, objectId=d81020444e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d81020444e26, replyNumber=0, likeNumber=98, createdTime=2020-12-14, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d81020444e26, moduleTitle=Ann Neurol：Covid-19患者Guillain-Barré综合征的发病率、临床特征、危险因素和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d81020444e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297496, encodeId=8d8d129e4967d, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Int J Antimicrob Agents：羟氯喹可显著降低COVID-19患者的病毒载量, objectType=article, longId=204232, objectId=a37c204232f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a37c204232f4, replyNumber=0, likeNumber=66, createdTime=2020-12-08, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a37c204232f4, moduleTitle=Int J Antimicrob Agents：羟氯喹可显著降低COVID-19患者的病毒载量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a37c204232f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297495, encodeId=2a91129e495e8, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Eur J Heart Fail：需要机械通气且伴有急性呼吸窘迫综合征的COVID-19患者血流动力学特征, objectType=article, longId=203786, objectId=0132203e866e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0132203e866e, replyNumber=0, likeNumber=96, createdTime=2020-11-28, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0132203e866e, moduleTitle=Eur J Heart Fail：需要机械通气且伴有急性呼吸窘迫综合征的COVID-19患者血流动力学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0132203e866e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297494, encodeId=c6ff129e494e9, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=JNNP:COVID-19患者癫痫样活动与癫痫发作, objectType=article, longId=203694, objectId=5a1b2036940a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a1b2036940a, replyNumber=0, likeNumber=101, createdTime=2020-11-25, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a1b2036940a, moduleTitle=JNNP:COVID-19患者癫痫样活动与癫痫发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a1b2036940a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297493, encodeId=363f129e49384, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关, objectType=article, longId=203607, objectId=7b4520360e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4520360e3c, replyNumber=0, likeNumber=96, createdTime=2020-11-23, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4520360e3c, moduleTitle=Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4520360e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297492, encodeId=1b2c129e49294, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Crit Care：NLR比对COVID-19患者疾病严重程度和死亡的预测价值, objectType=article, longId=203494, objectId=1bb2203494ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bb2203494ba, replyNumber=0, likeNumber=67, createdTime=2020-11-18, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bb2203494ba, moduleTitle=Crit Care：NLR比对COVID-19患者疾病严重程度和死亡的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bb2203494ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297491, encodeId=67a7129e49123, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%, objectType=article, longId=203491, objectId=bf832034914b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf832034914b, replyNumber=0, likeNumber=47, createdTime=2020-11-18, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf832034914b, moduleTitle=Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf832034914b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297490, encodeId=2990129e49008, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率, objectType=article, longId=203337, objectId=625b20333ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625b20333ea4, replyNumber=0, likeNumber=60, createdTime=2020-11-15, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625b20333ea4, moduleTitle=BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625b20333ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297489, encodeId=3663129e489b5, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实, objectType=article, longId=203135, objectId=8aa72031352f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aa72031352f, replyNumber=0, likeNumber=60, createdTime=2020-11-10, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aa72031352f, moduleTitle=CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aa72031352f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297488, encodeId=3e1f129e4885a, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验, objectType=article, longId=203072, objectId=4a132030e2bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a132030e2bd, replyNumber=0, likeNumber=67, createdTime=2020-11-09, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a132030e2bd, moduleTitle=FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a132030e2bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297487, encodeId=f6ad129e487be, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=诺华的Ilaris无法降低COVID-19患者的死亡率, objectType=article, longId=203010, objectId=f0a3203010db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a3203010db, replyNumber=0, likeNumber=50, createdTime=2020-11-08, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a3203010db, moduleTitle=诺华的Ilaris无法降低COVID-19患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0a3203010db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297486, encodeId=3c12129e486a9, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=JCEM：胸椎骨折在COVID-19患者中常见且可预测疾病预后, objectType=article, longId=202394, objectId=82d8202394fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82d8202394fa, replyNumber=0, likeNumber=165, createdTime=2020-10-24, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82d8202394fa, moduleTitle=JCEM：胸椎骨折在COVID-19患者中常见且可预测疾病预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82d8202394fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297485, encodeId=845f129e485a7, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=老药新用：氟伏沙明或可用于早期治疗轻度COVID-19患者, objectType=article, longId=201811, objectId=ec0f201811b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec0f201811b2, replyNumber=0, likeNumber=63, createdTime=2020-10-09, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec0f201811b2, moduleTitle=老药新用：氟伏沙明或可用于早期治疗轻度COVID-19患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec0f201811b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297484, encodeId=327f129e484ad, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=J Allergy Clin Immunol：鲁索利替尼治疗重症COVID-19患者显示出积极的疗效, objectType=article, longId=201686, objectId=49ab201686bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ab201686bd, replyNumber=0, likeNumber=69, createdTime=2020-10-06, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ab201686bd, moduleTitle=J Allergy Clin Immunol：鲁索利替尼治疗重症COVID-19患者显示出积极的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ab201686bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297483, encodeId=ec92129e483e4, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=NAt BME:COVID-19患者早期血清转化的超灵敏高分辨率分析, objectType=article, longId=201427, objectId=eb8620142ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8620142ef7, replyNumber=0, likeNumber=66, createdTime=2020-10-02, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8620142ef7, moduleTitle=NAt BME:COVID-19患者早期血清转化的超灵敏高分辨率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb8620142ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297482, encodeId=d996129e48266, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Eur Respir J：哮喘和哮喘药物对COVID-19患者预后的影响, objectType=article, longId=201421, objectId=80702014212f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80702014212f, replyNumber=0, likeNumber=78, createdTime=2020-10-02, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80702014212f, moduleTitle=Eur Respir J：哮喘和哮喘药物对COVID-19患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80702014212f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297481, encodeId=eb30129e481dc, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Gastroenterology：法莫替丁的使用与住院COVID-19患者的临床结果改善相关, objectType=article, longId=201154, objectId=8e30201154a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e30201154a0, replyNumber=0, likeNumber=71, createdTime=2020-09-26, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e30201154a0, moduleTitle=Gastroenterology：法莫替丁的使用与住院COVID-19患者的临床结果改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e30201154a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297480, encodeId=2a01129e48010, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Eur Respir J：静脉注射甲基强的松龙治疗重症COVID-19患者的疗效, objectType=article, longId=200875, objectId=30b82008e56b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30b82008e56b, replyNumber=0, likeNumber=95, createdTime=2020-09-20, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30b82008e56b, moduleTitle=Eur Respir J：静脉注射甲基强的松龙治疗重症COVID-19患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30b82008e56b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297479, encodeId=eaee129e47931, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=礼来公布新冠病毒中和抗体II期概念验证数据：降低门诊COVID-19患者72%住院风险, objectType=article, longId=200842, objectId=3ec8200842bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ec8200842bc, replyNumber=0, likeNumber=84, createdTime=2020-09-19, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ec8200842bc, moduleTitle=礼来公布新冠病毒中和抗体II期概念验证数据：降低门诊COVID-19患者72%住院风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ec8200842bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

COVID-19患者

2020-05-29

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Crit Care：COVID-19患者使用皮质类固醇治疗的疗效

2020-12-17

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Ann Neurol：Covid-19患者Guillain-Barré综合征的发病率、临床特征、危险因素和结局

2020-12-14

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Int J Antimicrob Agents：羟氯喹可显著降低COVID-19患者的病毒载量

2020-12-08

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Eur J Heart Fail：需要机械通气且伴有急性呼吸窘迫综合征的COVID-19患者血流动力学特征

2020-11-28

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

JNNP:COVID-19患者癫痫样活动与癫痫发作

2020-11-25

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关

2020-11-23

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Crit Care：NLR比对COVID-19患者疾病严重程度和死亡的预测价值

2020-11-18

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Science Advances：JAK抑制剂Baricitinib将新冠COVID-19患者死亡率降低71%

2020-11-18

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

BTK抑制剂Calquence降低了COVID-19患者体内炎症，但未能改善生存率

2020-11-15

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实

2020-11-10

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验

2020-11-09

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

诺华的Ilaris无法降低COVID-19患者的死亡率

2020-11-08

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

JCEM：胸椎骨折在COVID-19患者中常见且可预测疾病预后

2020-10-24

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

老药新用：氟伏沙明或可用于早期治疗轻度COVID-19患者

2020-10-09

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

J Allergy Clin Immunol：鲁索利替尼治疗重症COVID-19患者显示出积极的疗效

2020-10-06

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

NAt BME:COVID-19患者早期血清转化的超灵敏高分辨率分析

2020-10-02

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Eur Respir J：哮喘和哮喘药物对COVID-19患者预后的影响

2020-10-02

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Gastroenterology：法莫替丁的使用与住院COVID-19患者的临床结果改善相关

2020-09-26

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Eur Respir J：静脉注射甲基强的松龙治疗重症COVID-19患者的疗效

2020-09-20

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

礼来公布新冠病毒中和抗体II期概念验证数据：降低门诊COVID-19患者72%住院风险

2020-09-19

科室
- - 订阅+
  - 更多科室
工具
服务